MAURIZI, NICCOLO'
 Distribuzione geografica
Continente #
NA - Nord America 1.439
EU - Europa 1.234
AS - Asia 307
AF - Africa 7
Totale 2.987
Nazione #
US - Stati Uniti d'America 1.436
RU - Federazione Russa 420
PL - Polonia 294
IT - Italia 197
IE - Irlanda 136
SE - Svezia 121
SG - Singapore 89
HK - Hong Kong 69
CN - Cina 64
IN - India 33
JO - Giordania 30
DE - Germania 16
CH - Svizzera 14
VN - Vietnam 13
ES - Italia 10
GB - Regno Unito 9
UA - Ucraina 6
KR - Corea 5
FR - Francia 4
RO - Romania 4
CA - Canada 3
GH - Ghana 3
CI - Costa d'Avorio 2
BE - Belgio 1
GE - Georgia 1
IR - Iran 1
MU - Mauritius 1
NL - Olanda 1
PT - Portogallo 1
SC - Seychelles 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 2.987
Città #
Warsaw 290
Santa Clara 262
Fairfield 174
Dublin 136
Chandler 118
Ashburn 91
Woodbridge 83
Seattle 77
Singapore 71
Wilmington 68
Cambridge 62
Lawrence 54
Houston 53
Altamura 52
Hong Kong 45
Ann Arbor 38
Mumbai 32
Florence 31
Princeton 30
Boston 27
Beijing 22
Shanghai 19
Moscow 18
Scandicci 16
Bern 14
Buffalo 14
Munich 14
San Diego 14
Dong Ket 12
Medford 10
New York 10
Barcelona 9
Grottaglie 7
Siena 7
Andover 6
Boardman 6
Falls Church 6
Fontebuona 6
Rome 5
Campi Bisenzio 4
Dearborn 4
Kent 4
Norwalk 4
Redmond 4
Salerno 4
Seoul 4
Accra 3
Castelfiorentino 3
Imola 3
Livorno 3
Los Angeles 3
Timisoara 3
Yubileyny 3
Abidjan 2
Bologna 2
Bondeno 2
Cesano Boscone 2
Easley 2
Hillsboro 2
London 2
Prato 2
St. Catharines 2
Thiene 2
Trinitapoli 2
Vicenza 2
Washington 2
West Jordan 2
Barletta 1
Berlin 1
Bruino 1
Brussels 1
Chicago 1
Council Bluffs 1
Dongyang 1
Duncan 1
Fuzhou 1
Genova 1
Gloucester 1
Guangzhou 1
Hanoi 1
Harbin 1
Hefei 1
Hounslow 1
Islington 1
Jiaxing 1
Jinan 1
Kilburn 1
Lecce 1
Mem Martins 1
Milan 1
Monte San Savino 1
Nanjing 1
Naples 1
Romola 1
Rui'an 1
Sesto Fiorentino 1
Shaoxing 1
Southwark 1
St Petersburg 1
Toronto 1
Totale 2.119
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 326
Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude 157
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 139
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy 135
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 132
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 132
Association of Obesity with Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy 111
The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy 111
Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2 108
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 107
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 102
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy 94
Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical Trials 93
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 92
Common presentation of rare cardiac diseases: Arrhythmias 91
Cardiomyopathies in children – inherited heart muscle disease: Overview of hypertrophic, dilated, restrictive and non-compaction phenotypes 88
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 87
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 85
Exercise testing in hypertrophic cardiomyopathy: A pathophysiological goldmine with protean clinical implications 83
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 83
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy 76
Feasibility of a combined mobile-health electrocardiographic and rapid diagnostic test screening for chagas-related cardiac alterations 73
Comparative analysis of a 4-lead portable smartphone-based versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 71
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 69
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 69
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 67
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 67
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era 63
β-blockers: Their new life from hypertension to cancer and migraine 60
Telemedicine cardiovascular screening program in low-income settings by smartphone based technology 50
null 7
Totale 3.028
Categoria #
all - tutte 9.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020469 0 0 0 0 21 37 103 101 82 48 61 16
2020/2021395 34 58 47 46 14 22 17 37 27 61 10 22
2021/2022211 5 8 17 7 4 11 10 18 19 15 34 63
2022/2023651 52 175 35 25 30 93 69 41 73 9 30 19
2023/2024264 6 23 30 11 13 60 16 61 5 13 15 11
2024/2025924 64 166 111 244 339 0 0 0 0 0 0 0
Totale 3.028